The ‘post-antibiotic’ era: are we doomed?
By Rosalind Tucker
Another case of bacterial resistance has been revealed in the latest of a long list of studies. As they reported in The Lancet Infectious Diseases, scientists have discovered a strain of E. coli with a resistance mechanism, emerging from a single gene mutation, that can be transferred between bacteria. These pathogens are immune to colistin, a drug often used as a last resort when combinations of other antibiotics are no longer effective. With antibiotics such as colistin losing their efficacy, and resistance genes spreading like wildfire, we are facing a post-antibiotic era, which some have dubbed the ‘antibiotic apocalypse’. Does this mean currently treatable infectious diseases will become fatal, as they were before antibiotics? Or are there alternative options to fight pathogenic bacteria?
Bacteria develop resistance naturally, as mutations that are advantageous to one bacterium get passed on thanks to its improved chance of survival. However, certain human practices speed up the process; most notably, misuse of antibiotics for treating viral infections and overuse of antibiotics in livestock fodder. Quite simply, the more frequently antibiotics are used, the quicker resistance will emerge.
The largest problem we face as antibiotic resistance spreads is the possibility that some common infections will no longer be treatable. Illnesses will last longer, complicate simple surgical procedures, render chemotherapy and radiotherapy too dangerous to use, and may even result in death. This process could have already begun, as the World Health Organisation states that there have been cases in ten countries where last resort antibiotic treatments have failed to treat gonorrhoea. Multi-drug resistant bacteria are also becoming an increasing concern. The best known example is MRSA (methicillin-resistant Staphylococcus aureus), a hospital-acquired infection, which is already a heavy burden to the health care service.
However, there are a few alternatives to antibiotics. The most familiar of these options to the scientific community is the use of bacteriophages. These are viruses which target and often kill bacteria. Bacteriophage therapies have been used since the early 20th century in Russia, and are a very promising alternative. The viruses are very specific to bacterial species, and their high occurrence in nature means plenty are available if resistance develops.
Further options can be derived from nature. For example, anti-microbial peptides (AMPs) are commonly found in plants, fungi and many animals, produced as part of their own immune response. These molecules can be produced and modified to increase their efficacy in treating infections. Several trials involving AMPs are now ongoing and, despite their high cost, they could be a reliable alternative to antibiotics.
Infections are often caused by bacteria that survive and spread within the body in an organised structure called a biofilm, like the plaque which forms on teeth. Biofilms appear as bacterial cells adhere together and communicate by a mechanism known as quorum sensing. It is possible, however, to inhibit this communication with molecules found in other bacteria or plants. Furthermore, synthetic compounds can be made which act in the same way. By inhibiting quorum sensing, and hence preventing the formation of biofilms, infections may also be stopped.
In addition, many species of bacteria are not harmful to us, and could even be used to fight against those that are. One way to achieve this is through the use of predatory bacteria. They feed on other species and are highly proliferative, meaning a small number could go a long way. Scientists are looking into ways predatory bacteria can be used therapeutically, as a recent study from Rutgers University and the University of Pittsburgh found two species capable of attacking pathogenic bacteria. This suggests that they have strong potential to take over from antibiotics when they lose their efficacy.
So, despite the increasing number of bacterial species becoming resistant to antibiotics, and the looming possibility that infections such as tuberculosis, gonorrhoea and Staphylococcus aureus may be life-threatening once again, hope is not lost. There are multiple avenues of research ongoing and we probably understand enough to prevent an antibiotic apocalypse from getting the better of us.
Photograph: National Institute of Allergy and Infectious Diseases via Flickr
